INS and type 2 diabetes mellitus: This suggests the potential role of IGF-1 as a novel therapeutic target, also in combination with insulin, in therapeutic strategies to repair impaired glucose metabolism in the treatment of dementia in sporadic Alzheimer’s disease and type 2 diabetes.